Published in J Antimicrob Chemother on June 07, 2005
Honey: its medicinal property and antibacterial activity. Asian Pac J Trop Biomed (2011) 1.40
The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis. Eur J Clin Microbiol Infect Dis (2009) 1.26
Medical honey for wound care--still the 'latest resort'? Evid Based Complement Alternat Med (2008) 1.24
The antibacterial activity of honey derived from Australian flora. PLoS One (2011) 1.22
Antimicrobial activity of two South African honeys produced from indigenous Leucospermum cordifolium and Erica species on selected micro-organisms. BMC Complement Altern Med (2008) 0.97
Honey in wound care: antibacterial properties. GMS Krankenhhyg Interdiszip (2007) 0.97
The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey. Eur J Clin Microbiol Infect Dis (2008) 0.95
Mechanism of Honey Bacteriostatic Action Against MRSA and VRE Involves Hydroxyl Radicals Generated from Honey's Hydrogen Peroxide. Front Microbiol (2012) 0.92
The intracellular effects of manuka honey on Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2009) 0.91
The effect of manuka honey on the structure of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2010) 0.91
Honey and cancer: sustainable inverse relationship particularly for developing nations-a review. Evid Based Complement Alternat Med (2012) 0.86
Therapeutic Manuka Honey: No Longer So Alternative. Front Microbiol (2016) 0.84
Neurological effects of honey: current and future prospects. Evid Based Complement Alternat Med (2014) 0.82
Honey and Health: A Review of Recent Clinical Research. Pharmacognosy Res (2017) 0.80
The Anti-Inflammatory and Antibacterial Action of Nanocrystalline Silver and Manuka Honey on the Molecular Alternation of Diabetic Foot Ulcer: A Comprehensive Literature Review. Evid Based Complement Alternat Med (2015) 0.78
Evaluation of the antibacterial activity of selected Pakistani honeys against multi-drug resistant Salmonella typhi. BMC Complement Altern Med (2015) 0.78
Does honey have the characteristics of natural cancer vaccine? J Tradit Complement Med (2012) 0.77
Ameliorative Effects of Acacia Honey against Sodium Arsenite-Induced Oxidative Stress in Some Viscera of Male Wistar Albino Rats. Biochem Res Int (2013) 0.76
Salvage of an infected titanium mesh in a large incisional ventral hernia using medicinal honey and vacuum-assisted closure: a case report and literature review. Hernia (2010) 0.76
Volatile compounds in honey: a review on their involvement in aroma, botanical origin determination and potential biomedical activities. Int J Mol Sci (2011) 0.76
Comparison of the effect of honey and miconazole against Candida albicans in vitro. Adv Biomed Res (2013) 0.75
Anti-carcinogenic and Anti-bacterial Properties of Selected Spices: Implications in Oral Health. Clin Nutr Res (2015) 0.75
Assessment of Microbial Load of Un-pasteurized Fruit Juices and in vitro Antibacterial Potential of Honey Against Bacterial Isolates. Open Microbiol J (2015) 0.75
Effects of Dietary Honey andArdehCombination on Chemotherapy- Induced Gastrointestinal and Infectious Complications in Patients with Acute Myeloid Leukemia: A Double-Blind Randomized Clinical Trial. Iran J Pharm Res (2016) 0.75
Role of honey in modern medicine. Saudi J Biol Sci (2016) 0.75
Safety of transtympanic application of 4 % manuka honey in a chinchilla animal model. Eur Arch Otorhinolaryngol (2013) 0.75
Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell (2000) 10.72
Net formation of phosphoenolpyruvate from pyruvate by Escherichia coli. Biochim Biophys Acta (1965) 3.03
Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med (1974) 2.97
A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol (1991) 2.74
The direct synthesis of phosphoenolpyruvate from pyruvate by Escherichia coli. Proc R Soc Lond B Biol Sci (1967) 2.39
Metabolism of methylglyoxal in microorganisms. Annu Rev Microbiol (1984) 2.32
The effectiveness of existing and modified cleaning regimens in a Welsh hospital. J Hosp Infect (2007) 2.28
Susceptibility of Helicobacter pylori to the antibacterial activity of manuka honey. J R Soc Med (1994) 2.22
Antibacterial activity of honey against strains of Staphylococcus aureus from infected wounds. J R Soc Med (1999) 2.09
A comparison of the sensitivity of wound-infecting species of bacteria to the antibacterial activity of manuka honey and other honey. J Appl Bacteriol (1992) 2.08
Modification of red cell membrane structure by cholesterol-rich lipid dispersions. A model for the primary spur cell defect. J Clin Invest (1975) 2.04
Activation of skeletal muscle phosphorylase kinase by adenosine triphosphate and adenosine 3',5'-monophosphate. J Biol Chem (1968) 2.03
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
A furosemide-sensitive cotransport of sodium plus potassium in the human red cell. J Clin Invest (1974) 1.91
The partial purification and some properties of two sucrases of Phaseolus vulgaris. Biochem J (1964) 1.90
Effect of corticosteroids on the human monocyte IgG and complement receptors. J Clin Invest (1975) 1.88
The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol (2002) 1.73
Abnormalities of cell-membrane fluidity in the pathogenesis of disease. N Engl J Med (1977) 1.68
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Honey stimulates inflammatory cytokine production from monocytes. Cytokine (2003) 1.63
Transient modulation and internalization of T4 antigen induced by phorbol esters. J Immunol (1986) 1.62
Neoplasms in persons treated with x-rays in infancy: fourth survey in 20 years. J Natl Cancer Inst (1975) 1.58
Catabolism of 3- and 4-hydroxyphenylacetate by the 3,4-dihydroxyphenylacetate pathway in Escherichia coli. J Bacteriol (1980) 1.57
Genetic mapping of a locus for triosephosphate isomerase on the genome of Escherichia coli K12. J Gen Microbiol (1970) 1.56
Platelet hypersensitivity induced by cholesterol incorporation. J Clin Invest (1975) 1.55
A high ratio of apoptosis to proliferation correlates with improved survival after radiotherapy for cervical adenocarcinoma. Int J Radiat Oncol Biol Phys (1999) 1.53
The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J Burn Care Rehabil (2002) 1.53
A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med (1977) 1.51
The utilization of itaconate by Pseudomonas sp. Biochem J (1964) 1.48
Pyruvate formation during the catabolism of simple hexose sugars by Escherichia coli: studies with pyruvate kinase-negative mutants. J Bacteriol (1977) 1.43
The Escherichia coli C homoprotocatechuate degradative operon: hpc gene order, direction of transcription and control of expression. Mol Gen Genet (1993) 1.39
Pseudomonas putrefaciens bacteremia. Rev Infect Dis (1989) 1.38
Platypnea and orthodeoxia: shunting associated with an aortic aneurysm. J Thorac Cardiovasc Surg (1997) 1.38
An Escherichia coli mutant defective in the NAD-dependent succinate semialdehyde dehydrogenase. Arch Microbiol (1982) 1.37
Wheelchair pushrim kinetics: body weight and median nerve function. Arch Phys Med Rehabil (1999) 1.37
Factors influencing the lipid composition and fluidity of red cell membranes in vitro: production of red cells possessing more than two cholesterols per phospholipid. Biochemistry (1978) 1.32
An evaluation of hospital cleaning regimes and standards. J Hosp Infect (2000) 1.32
Stimulation of TNF-alpha release in monocytes by honey. Cytokine (2001) 1.30
Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells. J Supramol Struct (1978) 1.29
Indication of a Lombard vocal response in the St. Lawrence River Beluga. J Acoust Soc Am (2005) 1.27
Manual wheelchair pushrim biomechanics and axle position. Arch Phys Med Rehabil (2000) 1.27
Fluorescent probe analysis of the lipid architecture of natural and experimental cholesterol-rich membranes. Biochemistry (1974) 1.26
Allelic modifications of the cg2 and cg1 genes do not alter the chloroquine response of drug-resistant Plasmodium falciparum. Mol Biochem Parasitol (2000) 1.25
The purification and properties of Escherichia coli methylglyoxal synthase. Biochem J (1972) 1.23
Bile salts and cholesterol in the pathogenesis of target cells in obstructive jaundice. J Clin Invest (1968) 1.22
Subcloning and nucleotide sequence of the 3,4-dihydroxyphenylacetate (homoprotocatechuate) 2,3-dioxygenase gene from Escherichia coli C. FEBS Lett (1990) 1.19
An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease. J Clin Invest (1972) 1.19
Carcinoma of the small bowel. A complication of regional enteritis. Cancer (1976) 1.18
Phorbol ester induction of leukemic cell differentiation is a membrane-mediated process. Proc Natl Acad Sci U S A (1982) 1.18
The Oligocene bottleneck and New Zealand biota: genetic record of a past environmental crisis. Proc Biol Sci (1995) 1.17
2-Phenylethylamine catabolism by Escherichia coli K12. J Gen Microbiol (1987) 1.16
Differentiation of human leukemias in response to 12-0-tetradecanoylphorbol-13-acetate in vitro. Blood (1980) 1.15
Shoulder imaging abnormalities in individuals with paraplegia. J Rehabil Res Dev (2001) 1.14
Sleep apnoea in acromegaly. Br Med J (1980) 1.13
Catabolism of 3-hydroxybenzoate by the gentisate pathway in Klebsiella pneumoniae M5a1. Arch Microbiol (1990) 1.12
Characteristics of the membrane defect in the hereditary stomatocytosis syndrome. Blood (1975) 1.11
Maturation of macroreticulocyte membranes in vivo. J Lab Clin Med (1972) 1.10
Anemia with spur cells: a red cell defect acquired in serum and modified in the circulation. J Clin Invest (1969) 1.10
Kinematic characterization of wheelchair propulsion. J Rehabil Res Dev (1998) 1.10
Biochemical and genetical studies on ribose catabolism in Escherichia coli K12. J Gen Microbiol (1970) 1.08
Pushrim forces and joint kinetics during wheelchair propulsion. Arch Phys Med Rehabil (1996) 1.07
Two succinic semialdehyde dehydrogenases are induced when Escherichia coli K-12 Is grown on gamma-aminobutyrate. J Bacteriol (1981) 1.07
Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer (2000) 1.07
Lipids of human red cell membrane: normal composition and variability in disease. Semin Hematol (1970) 1.05
The role of membrane lipids in the survival of red cells in hereditary spherocytosis. J Clin Invest (1969) 1.05
Two ribose-5-phosphate isomerases from Escherichia coli K12: partial characterisation of the enzymes and consideration of their possible physiological roles. Eur J Biochem (1975) 1.05
The mechanism of the phosphoenolpyruvate synthase reaction. Biochim Biophys Acta (1967) 1.04
Methylglyoxal synthase. Methods Enzymol (1975) 1.03
SMARTWheels: development and testing of a system for measuring manual wheelchair propulsion dynamics. IEEE Trans Biomed Eng (1993) 1.03
Molecular cloning, expression, and analysis of the genes of the homoprotocatechuate catabolic pathway of Escherichia coli C. J Bacteriol (1988) 1.01
Tumor vascularity: a histological measure of angiogenesis and hypoxia. Cancer Res (2001) 1.01
Honey in wound care. J Wound Care (1999) 1.01
Genetic studies on ribose 5-phosphate isomerase mutants of Escherichia coli K-12. J Bacteriol (1974) 0.99
Domain preference in iron removal from human transferrin by the bacterial siderophores aerobactin and enterochelin. Eur J Biochem (1988) 0.99
Concanavalin A mediated attachment and ingestion of red blood cells by macrophages. Exp Cell Res (1975) 0.99
Role of the spleen in membrane conditioning and hemolysis of spur cells in liver disease. N Engl J Med (1974) 0.98
Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia. J Lab Clin Med (1977) 0.98
pH-dependent nuclear magnetic resonance spectra of 15 N-enriched glycine. Line shape and relaxation studies. J Am Chem Soc (1973) 0.98
2-phenylethylamine catabolism by Escherichia coli K-12: gene organization and expression. Microbiology (1997) 0.98
An evaluation of different methods for the recovery of meticillin-resistant Staphylococcus aureus from environmental surfaces. J Hosp Infect (2006) 0.98
Accuracy and complication rates of US-guided vacuum-assisted core breast biopsy: initial results. Radiology (2000) 0.97
An evaluation of four CT-MRI co-registration techniques for radiotherapy treatment planning of prone rectal cancer patients. Br J Radiol (2012) 0.97
Decreased fluidity of red cell membrane lipids in abetalipoproteinemia. J Clin Invest (1977) 0.96
Honey and sugar as a dressing for wounds and ulcers. Trop Doct (2000) 0.96
Concanavalin A-mediated binding and sphering of human red blood cells by homologous monocytes. J Exp Med (1976) 0.96
Small-cell carcinoma of the urinary bladder: 10-year experience. Clin Oncol (R Coll Radiol) (2004) 0.95
Three-dimensional pushrim forces during two speeds of wheelchair propulsion. Am J Phys Med Rehabil (1997) 0.95
Osteochondral fractures of the dome of the talus. J Bone Joint Surg Am (1989) 0.95
The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey. Eur J Clin Microbiol Infect Dis (2008) 0.95
The utilisation of D-galactonate and D-2-oxo-3-deoxygalactonate by Escherichia coli K-12. Biochemical and genetical studies. Arch Microbiol (1978) 0.95
Cloning, sequencing and expression in Escherichia coli of two Rhizobium sp. genes encoding haloalkanoate dehalogenases of opposite stereospecificity. Eur J Biochem (1996) 0.95
Isolation and mapping of Escherichia coli K12 mutants defective in phenylacetate degradation. J Gen Microbiol (1985) 0.95
Red cell cholesterol enrichment and spur cell anemia in dogs fed a cholesterol-enriched atherogenic diet. J Lipid Res (1980) 0.94
Succinic semialdehyde dehydrogenases of Escherichia coli: their role in the degradation of p-hydroxyphenylacetate and gamma-aminobutyrate. Eur J Biochem (1981) 0.94
Manuka honey used to heal a recalcitrant surgical wound. Eur J Clin Microbiol Infect Dis (2001) 0.94
D-Galactonate utilisation by enteric bacteria. The catabolic pathway in Escherichia coli. FEBS Lett (1977) 0.94